BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Feb 11, 2022
Distillery Therapeutics

MiR-675 for facioscapulohumeral muscular dystrophy

Items per page:
1 - 1 of 1
Username